Advancing Medicine with Breakthrough Science
Seal Rock Therapeutics is a clinical-stage biotechnology company targeting critical mechanisms of organ injury, inflammation, and fibrosis caused by genetic, environmental, metabolic and age-related factors.
We are committed to the discovery and development of first-in-class kinase inhibitors to treat diseases with limited treatment options.
Our Science
A robust drug discovery platform identifying next generation kinase inhibitors.
Learn more
Pipeline
Our current programs focus on liver and central nervous system diseases with significant unmet medical need.
Learn more
Our Team
The Seal Rock management team brings experience from leadership roles at successful public and private biopharma companies. Seal Rock receives clinical and scientific guidance from internationally recognized experts.
Learn more
